Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow GeoVax Labs, Inc.

Get SEC filing alerts via email and in your feed for GeoVax Labs, Inc.

GOVX GOVXW

GeoVax Labs, Inc.

About GeoVax Labs, Inc.

GeoVax Labs, Inc. is a biotechnology company developing vaccines and immunotherapies for infectious diseases and cancers. Its portfolio includes COVID-19 vaccines, oncolytic cancer therapies, and vaccines for Mpox, smallpox, Ebola, Zika, malaria, and hemorrhagic fevers. Utilizing proprietary MVA virus-like particle platforms, GeoVax focuses on safe, durable, and broad immune responses for global health and biodefense markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from GeoVax Labs, Inc.

1
1
GeoVax Labs, Inc. GeoVax Labs Reports No Revenue and Continued Net Loss in Q1 2026

Via official filing (AI summary) | 20 days ago | 0 comments

2
1
GeoVax Labs, Inc. GeoVax Labs Reports $21.5 Million Net Loss for Fiscal Year 2025, Plans Phase 3 Trial for GEO-MVA Vaccine

Via official filing (AI summary) | about 2 months ago | 0 comments

3
1
GeoVax Labs, Inc. GeoVax Labs Reports Revenue Decline and Increased Net Losses in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
GeoVax Labs, Inc. GeoVax Labs Reports Revenue Growth to $852K in Q2 2025 Despite Increased Net Loss

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
GeoVax Labs, Inc. GeoVax Labs Reports $1.6 Million Revenue in Q1 2025, Faces Contract Termination

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
GeoVax Labs, Inc. GeoVax Labs Reports $25 Million Net Loss and $3.95 Million Revenue for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
GeoVax Labs, Inc. GeoVax Labs Reports Increased Cash and Revenue, But Remains Concerned About Funding

Via official filing (AI summary) | over 1 year ago | 0 comments